While Venn Life looks for a successor, Chief Executive Tony Richardson will take over Hartshorn's responsibilities.
Shares were down 1.7% on Wednesday at
Wed, 21st Mar 2018 11:03
While Venn Life looks for a successor, Chief Executive Tony Richardson will take over Hartshorn's responsibilities.
Shares were down 1.7% on Wednesday at
Clinical research and development group Venn Life Sciences Holdings has confirmed Jonathan Hartshorn has begun his tenure as the group's new chief financial officer. The London-listed company had appointed Hartshorn, who left his role as head of finance for the onshore division of Mainstream Renewab
Read more